CRPPA and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: In particular, ISPD mutations appear to be responsible for a relatively high proportion of dystroglycanopathies within the most severe clinical spectrum [13, 14, 17], although they have also been described in a few LGMD cases [28–30].